Data / Form D filings / Circulate Health, Inc.
Circulate Health, Inc.: Form D filings
Circulate Health, Inc., a biotechnology company in Seattle, WA, filed 2 Form D notices with the SEC between 2025 and 2026. The latest, on January 9, 2026, reports $13 million sold of a $13 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1424 11TH AVE STE 400, Seattle, WA, 98122
- Phone
- (206) 289-0097
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2078196
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | Amendment | $13,000,000 | $13,000,000 | 4 | Jun 11, 2025 | sec.gov | |
| Oct 22, 2025 | New notice | $11,999,999 | $10,600,001 | $1,399,998 | 3 | Jun 11, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brad Younggren | Executive Officer, Director, Promoter | |
| Uri Greenwald | Director | |
| Robbie Schwietzer | Executive Officer |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Jan 5, 2026 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Circulate Health, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.